United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,340,100 | 1,593,100 | 1,899,900 | 1,697,200 | 1,553,900 |
| Marketable Securities | 1,427,500 | 1,455,600 | 1,421,400 | 1,569,800 | 1,772,600 |
| Receivables | 297,700 | 379,300 | 322,000 | 279,300 | 341,800 |
| Inventories | 176,500 | 169,200 | 165,400 | 157,900 | 146,700 |
| Other current assets | 252,200 | 229,700 | 131,100 | 169,700 | 185,400 |
| TOTAL | $3,494,000 | $3,826,900 | $3,939,800 | $3,873,900 | $4,000,400 |
| Non-Current Assets | |||||
| PPE Net | 1,555,600 | 1,362,400 | 1,302,700 | 1,222,400 | 1,156,700 |
| Investments And Advances | 1,567,300 | 1,917,700 | 1,710,700 | 1,475,300 | 1,279,400 |
| Other Non-Current Assets | 734,200 | 801,000 | 790,700 | 792,400 | 686,600 |
| TOTAL | $3,857,100 | $4,081,100 | $3,804,100 | $3,490,100 | $3,122,700 |
| Total Assets | $7,351,100 | $7,908,000 | $7,743,900 | $7,364,000 | $7,123,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | 200,000 | 300,000 | 400,000 |
| Accounts payable and accrued liabilities | 468,000 | 432,000 | 367,000 | 344,500 | 363,900 |
| Other current liabilities | 78,300 | 95,100 | 154,500 | 93,600 | 109,500 |
| TOTAL | $546,300 | $527,100 | $721,500 | $738,100 | $873,400 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 214,600 | 207,300 | 215,200 | 181,900 | 148,800 |
| TOTAL | $214,600 | $207,300 | $215,200 | $181,900 | $148,800 |
| Total Liabilities | $760,900 | $734,400 | $936,700 | $920,000 | $1,022,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,057 | 45,226 | 45,107 | 44,912 | 44,645 |
| Common Shares | 800 | 800 | 800 | 800 | 700 |
| Retained earnings | 8,192,600 | 7,853,900 | 7,544,400 | 7,222,200 | 6,920,900 |
| Other shareholders' equity | 100 | 500 | -700 | -2,900 | 7,100 |
| TOTAL | $6,590,200 | $7,173,600 | $6,807,200 | $6,444,000 | $6,100,900 |
| Total Liabilities And Equity | $7,351,100 | $7,908,000 | $7,743,900 | $7,364,000 | $7,123,100 |